Edition:
United Kingdom

Francesco Guarascio

EU criticises 'hasty' UK approval of COVID-19 vaccine

03 Dec 2020

BRUSSELS The European Union criticised Britain's rapid approval of Pfizer and BioNTech's COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot.

EU criticises 'hasty' UK approval of COVID-19 vaccine

02 Dec 2020

BRUSSELS The European Union criticised Britain's rapid approval of Pfizer and BioNTech's COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot.

EU seeks to bypass patents to boost drugs access in crises

25 Nov 2020

BRUSSELS The European Union is planning bold measures to boost its access to drugs, from sidestepping patent rights in emergencies to offering incentives for companies to shift production to Europe, according to EU documents published on Wednesday.

EU seeks fast-track bypassing of pharma patents in emergencies

25 Nov 2020

BRUSSELS The European Union wants faster procedures to produce generic versions of drugs without the consent of patent holders, an EU document says, in a move meant to bypass usual intellectual rights protections in exceptional circumstances.

EU secures 160 million doses of Moderna's COVID-19 vaccine

24 Nov 2020

BRUSSELS (Reuters) -The European Union has struck a deal for up to 160 million doses of U.S. firm Moderna's COVID-19 vaccine candidate, the head of the European Commission said on Tuesday, taking the EU's potential stock of COVID-19 shots to nearly 2 billion.

EU plans easier access to generics in potential blow to big drugmakers

23 Nov 2020

BRUSSELS The European Commission wants to make it easier for patients to access cheaper, generic medicines, a draft EU document seen by Reuters shows, in a move that could cut the revenues of big pharmaceutical firms.

EU plans easier access to generics in potential blow to big drugmakers

23 Nov 2020

BRUSSELS, Nov 23 The European Commission wants to make it easier for patients to access cheaper, generic medicines, a draft EU document seen by Reuters shows, in a move that could cut the revenues of big pharmaceutical firms.

Exclusive: EU could pay over $10 billion for Pfizer and CureVac vaccines - source

20 Nov 2020

BRUSSELS The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters. | Video

World News